IB Acquisition Corp. Discloses Full Terms of $106M Convertible Notes and $50M Equity Line to Fund GNQ Merger
IBAC is trading near its 52-week low of $10.19 (8.3% above the low).
Summary
IB Acquisition Corp. filed the full agreement text for its $106M convertible note financing and $50M equity line to fund the GNQ Insilico merger, revealing highly dilutive terms including 12% interest, $10 conversion price, and removal of the Minimum Cash condition.
Key Events · Financing and Capital Events · IBAC
-
$106M Convertible Note Financing
Securities Purchase Agreement with ATW Quantum Bio LLC provides up to $106.47M in senior secured convertible notes, with $16.47M initial closing. Notes carry 12% interest (18% on default), $10.00 conversion price, and are secured by substantially all assets.
-
$50M Equity Purchase Facility
ELOC with SZOP Opportunities I LLC allows sale of up to $50M in newly issued shares at 97-98% of market price, with a $675,000 commitment fee note and 4.99% ownership blocker.
-
Minimum Cash Condition Removed
Amendment No. 1 to the Business Combination Agreement deletes the Minimum Cash closing condition, reducing deal certainty protections for existing shareholders.
-
Sponsor Lock-Up Released
610,500 Private Placement Units held by sponsor I-B Good Works 4, LLC are released from the six-month lock-up restriction, allowing earlier sale.
Analysis · IBAC · Industrial Applications And Services
This 425 filing lays out the complete agreement text for the $106M convertible note financing and $50M equity line first disclosed in the concurrent 8-K. The terms are highly dilutive and coercive: 12% interest (18% on default), $10.00 conversion price, 135% redemption premium, and a first-priority security interest on substantially all assets. The removal of the Minimum Cash condition weakens existing shareholder protections. The ELOC allows sales at 97-98% of market price with a 4.99% ownership blocker. This financing is critical to completing the GNQ Insilico merger before the September 28 deadline, but comes at significant cost to existing shareholders.
How filings like this one have moved
In the 30 days to Oct 17, 2026, 44.5% of the 301 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.39%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, IBAC was trading at $11.04 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $55.3M. The 52-week trading range was $10.19 to $11.64. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.